This workbook contains an initial list of opportunities that stakeholders from various sectors can undertake to complement the federal efforts detailed in the 100-page Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis. It was created to assist organizations and stakeholders in identifying additional innovative and actionable (specific and detailed) opportunities to advance each of the Action Plan’s six priority areas. This workbook accompanies the Action Plan found at: https://www.aids.gov/pdf/viral-hepatitis-action-plan.pdf.
TB 101 for Health Care Workers is a web-based course designed to educate newly hired health care workers about basic concepts related to TB prevention and control in the U.S. Continuing education (CE) is offered free of charge for various professions based on approximately 1 hour of instruction. Upon successful completion of the course, exam, and evaluation, a CE certificate will be issued by CDC Training and Continuing Education Online. This course is also available in English.
This report provides guidelines regarding the prevention of needlestick injuries in health care settings. Bloodborne pathogens that may be transmitted during needlestick injuries include HIV, hepatitis B, and hepatitis C. The report identifies activities associated with needlestick injuries and describes Occupational Safety and Health Administration (OSHA) and Food and Drug Administration (FDA) guidelines for the prevention of such injuries in the workplace.
This report updates previous US Public Health Service recommendations for the management of health-care personnel (HCP) who have occupational exposure to blood and other body fluids that may contain Hepatitis B, Hepatitis C, or HIV/AIDS. It contains recommendations for Hepatitis B Virus postexposure management including initiation of hepatitis B vaccine series to any susceptible, unvaccinated person who sustains blood or body fluid exposure. Guidance is provided to clinicians and exposed HCP for selecting the appropriate HBV postexposure prophylaxis (PEP).
This report updates previous US Public Health Service recommendations for the management of health-care personnel (HCP) who experience occupational exposure to blood and/or other body fluids that might contain human immunodeficiency virus (HIV). Although the principles of exposure management have not changed, recommended HIV postexposure prophylaxis (PEP) regimens and the duration of HIV follow-up testing for exposed personnel have been updated.
This report is a cross-agency action plan to confront the significant cause of viral hepatitis morbidity and mortality. Multiple federal agencies identified strategic actions to be undertaken beginning in 2014 and continuing through 2016. This report is meant to articulate robust and dynamic steps for improving viral hepatitis prevention and the care and treatment available to infected individuals.